Evidence map›Paper›PMID 41080304›Full record

ArticleCureus2025

Mpox in a Gynecological Setting: A Case Report.

Yaw Abrefa Safo, Dorothy Sackey

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yaw Abrefa SafoObstetrics and Gynaecology, Tema General Hospital, Tema, GHA.
Dorothy SackeyPaediatrics and Child Health, Catholic Hospital Battor, Tema, GHA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monkeypox, now called mpox, is a DNA viral-associated infection with both zoonotic and person-to-person transmission. It typically starts with the onset of prodromal symptoms followed by maculopapular or vesicular rashes at the site of primary infection, which later spreads in a disseminated fashion. The clinical presentation and disease severity of Mpox infection have varied immensely, mostly depending on the viral strain, the route of transmission, host susceptibility, and the quantity of virus inoculated. We present a 24-year-old female patient with no comorbidities who developed multiple vulval rashes and purulent vaginal discharge. Mpox infection from clade II (formerly West African clade) with sub-clade IIa was confirmed by polymerase chain reaction (PCR). The patient was managed with supportive care at our Infectious Disease Centre and later discharged home to continue isolation until all scabs had fallen off. Given the heterogeneous presentation of mpox disease, obstetricians and gynecologists should maintain a high index of suspicion in patients with genital lesions. Establishment and optimization of PCR protocols in the sub-Saharan region are necessary for prompt confirmation and management.

Indexed as

epidermiologygenital rashghanagynecologymonkeypoxmpoxvulval lesions

Identifiers

PMID41080304
PMCPMC12514947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.